|
Volumn 47, Issue 2, 1999, Pages 172-177
|
The role of alpha-interferon in multiple myeloma
|
Author keywords
Chemoterapy; Cytokine treatment; Interferon alpha; Maintenance therapy; Meta analysis; Multiple myeloma
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
DEXAMETHASONE;
MELPHALAN;
PREDNISONE;
STEROID;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
FEVER;
GASTROINTESTINAL TOXICITY;
HEALTH CARE COST;
HUMAN;
META ANALYSIS;
MULTIPLE MYELOMA;
MYALGIA;
NEUROTOXICITY;
PATHOPHYSIOLOGY;
PROGNOSIS;
QUALITY OF LIFE;
SKIN MANIFESTATION;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INTERFERON-ALPHA;
MULTIPLE MYELOMA;
REMISSION INDUCTION;
STEROIDS;
TUMOR CELLS, CULTURED;
|
EID: 0033032843
PISSN: 03698114
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (41)
|